From: Immunological response in mice bearing LM3 breast tumor undergoing Pulchellin treatment
Pulchellin (P group) | Tumor control (T group) | Healthy mice (N group) | |
---|---|---|---|
% CD11b+CD54+ | 35.8 ± 2.6##*** | 24.7 ± 2.2 | 23.1 ± 1.4 |
% CD11b+CD80+ | 5.3 ± 1.3##** | 1.1 ± 0.4 | 1.5 ± 0.2 |
% CD11c+MHCII+ | 1.5 ± 0.1## | 2.8 ± 0,5** | 1.2 ± 0.1 |
% CD11c+CD86+ | 0.2 ± 0.1# | 0.4 ± 0.1* | 0.2 ± 0.1 |
%CD3+CD4+ | 9.0 ± 0.3*** | 8.5 ± 0.2*** | 17.6 ± 1.0 |
% CD4+CD25+ | 0.1 ± 0.1## | 1.0 ± 0.3** | 0.1 ± 0.1 |
% CD3+CD8+ | 2.6 ± 0.4*** | 2.5 ± 0.4*** | 6.7 ± 0.4 |